Get early access! Join the Twelve Data AI Assistant waitlist now.

LPGO

OMX
Market closed
Access this stock data via API
Subscribe
Lipigon Pharmaceuticals AB
0
0
0%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 0 1.3M 0 9.0M
Cost of revenue
Gross profit
Operating expense
Research & development
Selling general and admin
Other operating expenses 6.6M 10.8M 5.0M 7.8M
Operating income -9.1M -11.1M -6.7M -357K
Non operating interest income
Income 0 382K 0 0
Expense 90K 10K 2K 58K
Other income expense
Pretax income -9.2M -10.7M -6.7M -415K
Tax provision 0 0 0 0
Net income -9.2M -10.7M -6.7M -415K
Basic EPS 0.0 -0.1 0.0 0.0
Diluted EPS 0.0 -0.1 0.0 0.0
Basic average shares 193.3M 193.3M 193.3M 168.9M
Diluted average shares 202.2M 202.2M 202.2M 202.2M
EBITDA -9.0M -10.7M -6.7M -351K
Net income from continuing op. -9.1M -11.1M -6.7M -357K
Minority interests
Preferred stock dividends 0 0 0 0
Market closed

Exchange is currently closed
Main market opens in 5 hours 14 minutes

03:45
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).